The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Basic Science of the Annual Scientific Meeting

The Basic Science of the Annual Scientific Meeting

July 1, 2010 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR/ARHP Annual Scientific Meeting is the premier event for specialists in the field of rheumatology. At this year’s meeting, basic researchers will have multiple opportunities to increase their knowledge, and there will be something for every interest.

You Might Also Like
  • ACR/ARHP Annual Meeting Offers Basic Science Track
  • 2017 in Review: Key Findings in Basic Science Highlighted at the ACR/ARHP Annual Meeting
  • 2010 Annual Scientific Meeting Ramping Up
Explore This Issue
July 2010
Also By This Author
  • View On-Demand Sessions & Content from ACR Convergence 2020

There are several exciting offerings planned for basic researchers, but they aren’t the only attendees who can benefit from basic science sessions—clinicians can attend these talks to obtain important information from the bench that will directly help them when they return to the bedside.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“There will be many wonderful basic science talks at the ACR’s annual meeting in Atlanta,” explains ACR Annual Meeting Planning Committee Member R. John Looney, MD. “As an academic clinician and someone involved in clinical trials, I will be particularly interested in talks that provide insight into the pathogenesis of autoimmune diseases and their complications. I have always been fascinated by these talks. As a bonus, they have proven to be an excellent source of ideas for new therapies.”

Here are a few basic science sessions the planning committee has identified as being of interest to both basic researchers and clinicians.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Innate Immunity

Innate immunity plays a key role in inflammatory diseases such as gout and pseudogout and can play a role in chronic autoimmune inflammation and inflammation induced by damage or injury. The molecular details of signals used in innate immunity are now being realized, raising the possibility of new therapeutic interventions. To get the latest updates on innate immunity, be sure to add these three sessions to your annual meeting itinerary:

  • ACR Immunology Updates for Clinicians: Innate Immunity and Inflammation (Monday, November 8; 9:00–10:00 am)
  • ACR Basic Science Symposium: Toll-like Receptors and Inflammation: Towards Innovative Treatment of Rheumatoid Arthritis (Monday, November 8; 2:30–4:00 pm)
  • ACR Basic Science Symposium: Cell Death: Receptors, Sensors, and Inflammatory Pathways (Wednesday, November 10; 2:30–4:00 pm)

Macrophages

Macrophages are ubiquitous and extremely adaptable. They can become Kupffer cells, type A synoviocytes, alveolar macrophages, or osteoclasts. They can clear debris, kill microorganisms, and enhance wound healing—or, they can cause chronic inflammation, fibrosis, osteolysis, and atherosclerosis. Understandably, regulating macrophage differentiation and activation has become a hot topic in rheumatology. If you are interested in macrophages, don’t miss the following sessions:

  • ACR Immunology Updates for the Clinicians: Macrophage Differentiation (Tuesday, November 9; 7:15–8:15 am)
  • ACR Basic Science Symposium: A Critical Role for Lipid Metabolism in the Interplay Between Atherosclerosis and Autoimmune Disorders (Wednesday, November 10; 4:30–6:00 pm)

Epigenetics

Epigenetics—the alteration of mesencymal cells to a more inflammatory and/or profibrotic phenotype—is one of the great challenges of chronic inflammation. Although there has been debate, this transformation appears to be due to heritable, nonmutational changes in gene regulation (i.e., epigenetic changes). Similarly, epigenetic changes in gene expression induced by DNA methylation inhibitors such as hydralazine or procainamide may be responsible for certain types of drug-induced lupus. These days, epigentics seems to be a growing topic of discussion, and below are two sessions that address this topic:

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
  • ACR Basic Science Symposium: The Revolution of Epigenetics in Autoimmunity (Monday, November 8; 4:30–6:00 pm)
  • ACR Immunology Updates for the Clinicians: Epigenetics 101 (Wednesday, November 10; 8:45–9:45 am)

Ready, Aim, Get Funded!

The ARHP Research Committee will hold a workshop called “Ready, Aim, Get Funded!” at the ACR/ARHP Annual Scientific Meeting in Atlanta on Wednesday, November 10. Specific aims are one of the most important pieces of the grant application, but often they are the most difficult to write. This workshop will teach a hands-on approach to writing strong specific aims, including examples of good and bad specific aims. Participants must bring a one-page draft of specific aims for an actual grant proposal for review and to get one-on-one expert feedback. Space is limited so register early at www.rheumatology.org/education.

Pages: 1 2 | Single Page

Filed Under: From the College, Meeting Reports Tagged With: Annual Meeting, Autoimmune, Basic research, Immunity, Stem CellsIssue: July 2010

You Might Also Like:
  • ACR/ARHP Annual Meeting Offers Basic Science Track
  • 2017 in Review: Key Findings in Basic Science Highlighted at the ACR/ARHP Annual Meeting
  • 2010 Annual Scientific Meeting Ramping Up
  • Atlanta My Way: ACR/ARHP Annual Scientific Meeting

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)